drugset / Trial / NCT01235715
The Use of Evicel to Reduce Blood Loss in Total Knee Replacement Surgery
RandomizedParallel-groupTriple-blindPrevention
Summary
Application of "Evicel" hemostatic matrix during operation for unilateral total knee replacement surgery (TKA) will result in decreased bleeding and postoperative drain output, a reduction in transfusion requirements, and less reduction of hemoglobin.
Timeline
- Start
- 2010-09
- Primary completion
- 2012-03
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fibrinogen Concentrate Human | Protein / enzyme biologic | — | — |